Bioventus Inc.BVSNASDAQ
Loading
Total debt minus cash and cash equivalents
3Y CAGR
-12.5%/yr
vs +26.4%/yr prior
5Y CAGR
+20.7%/yr
Recent deceleration
Acceleration
-38.8pp
Decelerating
Percentile
P56
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $260.11M | -11.5% |
| 2024 | $294.05M | -17.8% |
| 2023 | $357.88M | -7.7% |
| 2022 | $387.88M | +23.6% |
| 2021 | $313.75M | +209.0% |
| 2020 | $101.54M | -23.9% |
| 2019 | $133.44M | -12.2% |
| 2018 | $152.05M | -20.6% |
| 2015 | $191.56M | +23.4% |
| 2014 | $155.20M | - |